Forbion European Acquisition Corp. (FRBN) Research
Forbion European Acquisition Corp. currently has no substantial business activities. Its primary purpose is to complete a strategic corporate transaction, such as a merger, stock exchange, asset acquisition, or restructuring, with other companies. The firm aims to pinpoint promising opportunities specifically within the European life sciences sector. Established in 2021, its registered office is located in Wilmington, Delaware.
Market snapshot
- Symbol
- FRBN
- Price
- $21.13
- Day change
- -1.68%
- Market cap
- $334.1M
- 52-week range
- 9.25-47.17
- Sector
- Financial Services
- Industry
- Shell Companies
Peer companies
- CIIG Capital Partners II, Inc. (CIIG)
- Compute Health Acquisition Corp. (CPUH)
- Social Capital Suvretta Holdings Corp. II (DNAB)
- Social Capital Suvretta Holdings Corp. IV (DNAD)
- Healthwell Acquisition Corp. I (HWEL)
- Rocket Internet Growth Opportunities Corp. (RKTA)
- Summit Healthcare Acquisition Corp. (SMIH)
- Sound Point Acquisition Corp I, Ltd (SPCM)
Recent insider activity
- Forbion Growth Sponsor FEAC I B.V. — D-Return (2000000 shares) on 2023-10-30
- Forbion Growth Sponsor FEAC I B.V. — D-Return (666666 shares) on 2023-10-30
- Forbion Growth Sponsor FEAC I B.V. — C-Conversion (1373496 shares) on 2023-10-27
- Forbion Growth Sponsor FEAC I B.V. — A-Award (1000000 shares) on 2023-10-27
- Forbion Growth Sponsor FEAC I B.V. — C-Conversion (1373496 shares) on 2023-10-27
Open Forbion European Acquisition Corp. (FRBN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.